Sio Gene Therapies Ownership | Who Owns Sio Gene Therapies?
Sio Gene Therapies Ownership Summary
Sio Gene Therapies is owned by 0.09% institutional investors, and 99.91% retail investors. Empower IS Eagle Mid Cap Growth SP is the top mutual fund, with 0.01% of its assets in Sio Gene Therapies shares.
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | -75.00% | 64,170 | -97.71% | - | 0.61% | - | -100.00% | - | -100.00% |
| Mar 31, 2023 | 4 | -88.57% | 2,797,297 | -84.95% | 3 | 0.60% | 2 | -85.71% | 1 | -91.67% |
| Dec 31, 2022 | 35 | 20.69% | 18,586,908 | -11.98% | 25 | 3.08% | 14 | 75.00% | 12 | 33.33% |
| Sep 30, 2022 | 29 | -3.33% | 21,117,126 | 2.12% | 28 | 3.63% | 8 | -33.33% | 9 | -18.18% |
| Jun 30, 2022 | 30 | -11.76% | 20,679,713 | 14.23% | 28 | 4.65% | 12 | 50.00% | 11 | -31.25% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Empower IS Eagle Mid Cap Growth SP | 4.39K | 0.01% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 23, 2021 | Cheruvu Pavan | Chief Executive Officer | Buy | $248.18K |
| Nov 24, 2020 | Pande Atul | - | Buy | $23.40K |
| Jul 08, 2020 | Pande Atul | - | Buy | $27.29K |
| Jul 08, 2020 | Cheruvu Pavan | Principal Executive Officer | Buy | $102.64K |
| Mar 16, 2020 | Pande Atul | - | Buy | $17.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2022 Q1 | - | - |
| 2021 Q4 | - | - |
| 2021 Q2 | - | - |
| 2021 Q1 | 1 | - |
| 2020 Q4 | 1 | - |
SIOX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools